2. Profile
  3. Sajoy P. Varghese

Sajoy P. Varghese MD FAPA

Sajoy P. Varghese
Designation
  • Assistant Professor
  • VA Northern California Health Care System
  • Addiction Recovery Treatment Services (Telepsychiatry)
  • Department of Psychiatry & Behavioral Sciences
  • University of California, Davis
  • Minneapolis VA Medical Center, VISN 23, Clinical Resource Hub
Contact Information
  • Sajoy.varghese [at] va.gov

Dr. Varghese is board certified in both General Psychiatry and Addiction Psychiatry/Medicine. Currently he is a telehealth staff psychiatrist at the Department of Veterans Affairs. He is interested to develop novel pharmacological agents and novel cognitive/behavioral interventions to prevent binge alcohol drinking in people with post-traumatic stress disorder.

  • Fellowship
    University of Illinois Chicago, Addiction Psychiatry (2012)
  • Residency
    Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital), Psychiatry (2011)
  • Internship
    Saint Elizabeth's Medical Center, Psychiatry (2007)
  • Medical School
    Vinnitsa Medical School (2003)
  • Board Certification
    Psychiatry, American Board of Psychiatry and Neurology
  • Board Certification
    Addiction Psychiatry, American Board of Psychiatry and Neurology
  • Board Certification
    Addiction Medicine, American Board of Addiction Medicine
  • Young Investigator Award, Research Colloquium, American Psychiatric Association (2018)

  • Translational Research in stress related disorders and Substance Use Disorders

  • Integrative Pharmacology in the Treatment of Substance Use Disorders (https://www.tandfonline.com/doi/full/10.1080/15504263.2023.2293854)

    Biedlingmaier AJ, Koola MM, Shad MU, John S, Reddy GG, Varghese SP. A Rare Case of Serotonin Syndrome With Buprenorphine and Other Serotonergic Medications. J Clin Psychopharmacol. 2023 May 29. doi: 10.1097/JCP.0000000000001707. 

    Title:  An Overview of Mindfulness-Oriented Addiction and Pain Recovery. J Nerv Ment Dis. 2022 Oct 1;210(10):808-810.
    doi: 10.1097/NMD.0000000000001497.
    PMID: 36179375.

    Title: Therapeutic Efficacy of Rhemercise: A Novel Mindfulness Technique in Patients With Opioid Use Disorder
    Date: 02-10-22
    PMID: 35144326
    DOI: doi.org/10.4088/PCC.21m03064

    Role of Spirituality in the Management of Major Depression and Stress-Related Disorders Varghese SP, Florentin OD, Koola MM Chronic Stress. 2021 Jan; 5:https://doi.org/10.1177/2470547020971232

    Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone Varghese SP, Kumari P, Wijegunaratne H, Yovankin T, Garlapati V, Koola MM Prim Care Companion CNS Disord. 2019 Jul; 21(4):https://doi.org/10.4088/PCC.19l02446 PMID: 31274259

    Chromatin switches during neural cell differentiation and their dysregulation by prenatal alcohol exposure Gavin DP, Grayson DR, Varghese SP, Guizzetti M Genes. 2017 May; 8(5): https://doi.org/10.3390/genes8050137

    Early Life Stress as a Risk Factor for Substance use Disorders: Clinical and Neurobiological Substrates.Varghese SP, Montalvo-Ortiz JL, Csernansky JG, Eiger RI, Herrold AA, Koola MM, Dong H Indian J Psychol Med. 2015 Jan; 37(1): 36-41. https://doi.org/10.4103/0253-7176.150816 PMID: 25722510 ISSN: 0253-7176

    Opioid use remits, depression remains Varghese SP, Koola MM, Eiger RI, Devens M Current Psychiatry. 2014 Jan; 13(8): 45-50. ISSN: 1537-8276

    Fludrocortisone in posttraumatic stress disorder: effective for symptoms and prazosin-induced hypotension. Vaishnav M, Patel V, Varghese SP, McCagh JC, Koola MM Prim Care Companion CNS Disord. 2014; 16(6):https://doi.org/10.4088/PCC.14l0167 PMID: 25834757 ISSN: 2155-7772

    High-dose prazosin for the treatment of post-traumatic stress disorder Koola MM, Varghese SP, Fawcett JA Therapeutic Advances in Psychopharmacology. 2014 Jan; 4(1): 43-47.https://doi.org/10.1177/2045125313500982 ISSN: 2045-1253